{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-049148","form_type":"8-K","ticker":"CNTN","cik":"0001861657","company_name":"Canton Strategic Holdings, Inc.","filed_at":"2024-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.148641+00:00","generated_at":"2026-05-29T06:45:55.438523+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Tharimmune raises $2.02M in private placement for TH104 development","bullets":["Gross proceeds of ~$2.02M from issuance of 961,446 common shares (or equivalents) and warrants for 480,723 shares at $2.10 per unit.","Warrants exercisable at $2.031/share, starting 6 months after issuance, expiring in 5.5 years.","Placement led by Gravitas Capital and SDS Capital Group; President Street Global as exclusive agent.","Net proceeds to fund clinical development of TH104 (pruritus in PBC) and working capital.","Closing expected on or about December 9, 2024, subject to customary conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-049148","json":"https://secwatch.observer/filing/0001493152-24-049148.json","markdown":"https://secwatch.observer/filing/0001493152-24-049148.md","text":"https://secwatch.observer/filing/0001493152-24-049148.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861657/000149315224049148/0001493152-24-049148-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861657/000149315224049148/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T06:45:55.438523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}